MedTech M&A 2025: What key factors are driving acquisitions in the Medical Devices market in 2025?
- Lloyd Price
- May 26
- 5 min read
Mergers and acquisitions (M&A) in the Medical Devices market are expected to see significant activity in 2025, driven by a confluence of technological advancements, evolving healthcare needs, economic factors, and a shifting regulatory landscape.
The MedTech M&A landscape in 2025 will be characterised by a strong emphasis on acquiring innovative technologies, particularly AI-driven solutions and digital health platforms, alongside strategic moves to consolidate market share, expand portfolios in high-growth areas, and optimise for profitability in a more favourable economic and regulatory environment.
Technological Advancements and Innovation
Cutting-Edge Technologies: The rapid evolution of technologies such as robotics, artificial intelligence (AI), miniaturisation, and connectivity is a major driver. Companies are acquiring firms with innovative technologies to enhance their product portfolios and maintain a competitive edge. For instance, acquisitions like Medtronic’s purchase of Nanovis’ nano-surface implant technology and Boston Scientific’s acquisition of SoniVie Ltd aim to integrate advanced solutions like AI-driven platforms and novel treatment modalities.
AI and Digital Health: The integration of AI into medical devices, particularly for diagnostics, remote monitoring, and personalized treatment, is fuelling M&A. Companies seek to acquire AI-driven platforms to streamline healthcare delivery and improve clinical outcomes, as seen in SyntheticMR’s acquisition of Combinostics Oy for its AI-driven diagnostic tools.
Focus on Specialised Capabilities: Acquisitions are targeting companies with specialised technologies, such as Integer’s acquisition of Precision Coating for advanced coating technology and Argon Medical’s purchase of SeQure and DraKon microcatheters for precise oncology interventions.
Market Consolidation
Fragmented Market: The medical device market remains highly fragmented, prompting companies to pursue M&A to consolidate market share, achieve economies of scale, and streamline operations. Larger entities acquire smaller, specialised firms to broaden their product portfolios and enhance competitiveness, as evidenced by deals like Caldera Medical’s acquisition of J&J MedTech’s Gynecare TVT family.
Global Expansion: Companies are acquiring firms to expand their geographic reach and access new markets. For example, Cormica’s acquisition of Focus Laboratories expanded its U.S. presence, while Philips’ sale of its Emergency Care business to Bridgefield Capital included a global brand licensing agreement.
Economic and Financial Factors
Favourable M&A Environment: Analysts predict a more favourable M&A environment in 2025 due to lower financing costs, a more permissive regulatory environment, and normalised market growth rates. Bank of America analysts noted that these factors could lead to an M&A boom, with companies like Boston Scientific and Johnson & Johnson expected to remain active.
Private Equity Involvement: Private equity (PE) firms are increasingly active, with significant capital to deploy. Deals like Carlyle Group’s $3.8 Billion acquisition of Baxter International’s renal care unit highlight PE’s role in driving M&A activity.
High Valuations and Strategic Tuck-Ins: While public company valuations have been elevated, acquisitions of private firms and strategic tuck-ins (e.g., Medtronic’s focus on smaller deals) allow companies to fill portfolio gaps without overpaying.
Regulatory and Policy Changes
Anticipated Regulatory Shifts: A potentially lighter regulatory environment in the U.S. under a new administration in 2025 is expected to accelerate M&A activity. This contrasts with the aggressive antitrust scrutiny under the previous administration, which slowed deals like Boston Scientific’s acquisition of Axonics.
Compliance and Quality Management: Companies are acquiring firms with robust regulatory compliance capabilities, such as Akkodis’ acquisition of Raland Compliance Partners, to navigate stringent FDA and international standards like ISO 13485.
Demographic and Healthcare Trends
Aging Population and Chronic Diseases: The growing demand for medical devices to address age-related conditions and chronic diseases (e.g., diabetes, cardiovascular diseases) drives M&A. Acquisitions like Globus Medical’s $250 million purchase of Nevro for spinal cord stimulation devices reflect the focus on chronic pain management and aging-related needs.
Shift to Outpatient and Non-Traditional Care Settings: The rise in patient volumes at alternative surgery centres and outpatient settings is pushing companies to acquire technologies that support these care models, such as minimally invasive devices and wearables.
Strategic Portfolio Diversification
Filling Portfolio Gaps: Companies are acquiring to diversify their offerings and address unmet clinical needs. For example, Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical strengthened its interventional cardiology portfolio, while Teleflex’s $823 million acquisition of Biotronik’s vascular intervention unit enhanced its vascular procedure capabilities.
Focus on High-Growth Segments: Key areas like interventional cardiology, peripheral vascular, soft tissue robotic surgery, and neuro modulation are seeing increased M&A activity due to their growth potential. Bank of America analysts highlighted these segments as strategic targets for 2025.
Supply Chain and Manufacturing Resilience
Nearshoring and Supply Chain Stability: Post-COVID supply chain disruptions have prompted companies to acquire firms that enhance manufacturing resilience and nearshoring capabilities. Aptyx’s acquisition of Medical Murray’s North Carolina facility for catheter-based products exemplifies this trend.
Advanced Manufacturing: Acquisitions like Medical Manufacturing Technologies’ purchase of GenX Medical for extrusion capabilities aim to bolster production efficiency and innovation.
Consumer-Driven Healthcare
Direct-to-Consumer Opportunities: The growing market for direct-to-consumer devices, such as continuous glucose monitors and wearables, is driving M&A. Companies are acquiring technologies that cater to health-conscious consumers, as noted in EY’s 2024 MedTech report.
In 2025, MedTech M&A is driven by the pursuit of innovative technologies, market consolidation, favourable economic conditions, regulatory shifts, demographic trends, portfolio diversification, supply chain resilience, and consumer-driven healthcare. Companies like Boston Scientific, Johnson & Johnson, and Medtronic are leading the charge, while private equity firms play a significant role. These factors collectively aim to enhance technological capabilities, expand market presence, and address evolving healthcare demands, positioning the medical device industry for significant growth and transformation
Nelson Advisors > Healthcare Technology M&A
.
Nelson Advisors specialise in mergers, acquisitions & partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk
Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital
We share our views on the latest Healthcare Technology mergers, acquisitions & partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb
Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk
#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide
Nelson Advisors LLP
Hale House, 76-78 Portland Place, Marylebone, London, W1B 1NT
Contact Us
Meet Us
Digital Health Rewired > 18-19th March 2025
NHS ConfedExpo > 11-12th June 2025
HLTH Europe > 16-19th June 2025
Comments